Skip to main content

Substitution mit Sexualhormonen in der Postmenopause

  • Chapter
Osteoporose

Part of the book series: Praktische Orthopädie ((PRAKORTHO,volume 41))

  • 112 Accesses

Zusammenfassung

Jede postmenopausale Hormonsubstitution bedarf einer Indikation und deren gelegentlicher Überprüfung. Die regelmäßige klinische Überwachung ermöglicht die Wirkungen der Therapie zu überprüfen, Nebenwirkungen zu erkennen und Modifikationen der Behandlung vorzunehmen. Da heute auch im menschlichen Organismus nicht sezernierte östrogene sowie synthetische Gestagene in der Hormonsubstitution eingesetzt werden, wäre wohl die Bezeichnung Hormontherapie korrekter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

Allgemeines/Übersichten/key studies/Symptomatik

  • Braendle W (2000) Das Klimakterium. Wissenschaftliche Verlagsgesellschaft Stuttgart. ISBN 3-8047-1712-8

    Google Scholar 

  • Dören M (1998) Hormonsubstitution in Klimakterium und Postmenopause — Vorschläge zur individualisierten Therapie. Thieme Verlag, Stuttgart New York, 2. Auflage. ISBN 3-13-107 362-4

    Google Scholar 

  • Stellungnahme der Deutschen Menopause Gesellschaft e. V. Hormonsubstitution in Klimakterium und Postmenopause. www.menopause-gesellschaft.de

    Google Scholar 

  • MacLennan A et al (2001) Oral replacement therapy versus placebo for hot flushes. (Cochrane Review) Cochrane Database Syst Rev (1); CD 002978

    Google Scholar 

  • Norman RJ et al (2000) Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution. (Cochrane Review) Cochrane Database Syst Rev (2); CD 001018

    Google Scholar 

  • Espeland MA et al (1995) Rationale, design, and conduct of the PEPI trial. Postmenopausal Estrogen/progestin Interventions. Control Clin Trials 16:3S–19S

    Article  PubMed  CAS  Google Scholar 

  • The Women’s Health Initiative Study Group (1998) Design of the Women’s Health Initiative Clinical trial and observational Study. Control Clin Trials 19:61–109

    Article  Google Scholar 

  • Barrett-Connor E, Stuenkel C (2001) Hormone replacement therapy (HRT) — risks and benefits. Int J Epidemiol 30:423–426

    Article  PubMed  CAS  Google Scholar 

  • Manson JE, Martin KA (2001) Postmenopausal hormone replacement therapy. New Engl J Med 345:34–40

    Article  PubMed  CAS  Google Scholar 

  • Hlatky MA et al (2002) Quality-of-life and depressive symptoms in postmenopausal women after receiving hormone therapy. JAMA 287:591–597

    Article  PubMed  CAS  Google Scholar 

  • Modelska K, Cummings St (2002) Tibolone for postmenopausal women: systematic review of randomized trials. J Clin Endocrinol Metab 87:16–23

    Article  PubMed  CAS  Google Scholar 

Osteoporose

  • O’Connell D et al (1998) A systematic review of the skeletal effects of estrogen therapy in postmenopausal women. II. An assessment of treatment effects. Climacteric 1:112–123

    Article  CAS  Google Scholar 

  • Komulainen M et al (1998) HRT and vit D in prevention of non-vertebral fractures in postmenopausal women; a 5-year randomized trial. Maturitas 31:5–54

    Article  Google Scholar 

  • Mosekilde L et al (2000) Hormonal replacement therapy reduces forearm fracture incidence in recent postmenopausal women — results of the Danish Osteoporosis Prevention Study. Maturitas 36:181–193

    Article  PubMed  CAS  Google Scholar 

  • Dören M, Samsioe G (2000) Prevention of Postmenopausal Osteoporosis with Estrogen Replacement Therapy and associated Compounds — Update on clinical trials since 1995-Human Reprod Update 6:419–426

    Article  Google Scholar 

  • Torgerson DJ, Bell-Syer SEM (2001) Hormone replacement therapy and prevention of nonvertebral fractures. JAMA 285:2891–2897 und Ergänzung der Meta-Analyse in JAMA 286:2097

    Article  PubMed  CAS  Google Scholar 

  • Nevitt MC et al (2001) The effect of estrogen plus progestin on knee symptoms and related disability in postmenopausal women: The Heart and Estrogen/Progestin Replacement Study, a randomized, double-blind,placebo-controlled trial. Arthritis Rheum 44:811–818

    Article  PubMed  CAS  Google Scholar 

  • Musgrove DS et al (2001) Back problems among postmenopausal women taking estrogen replacement therapy: the study of osteoporotic fractures. Spine 26:1606–1612

    Article  Google Scholar 

  • Cauley JA et al (2001) Effects of hormone replacement on clinical fractures and height loss: The Heart and Estrogen/Progestin Replacement Study (HERS). Am J Med 110:442–450

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Dören, M. (2002). Substitution mit Sexualhormonen in der Postmenopause. In: Hedtmann, A., Götte, S. (eds) Osteoporose. Praktische Orthopädie, vol 41. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-642-57442-9_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-57442-9_8

  • Publisher Name: Steinkopff, Heidelberg

  • Print ISBN: 978-3-7985-1300-6

  • Online ISBN: 978-3-642-57442-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics